BIOMATERIAL SUBSTRATES--S. EPIDERMIDIS & PATHOGENICITY

生物材料基材--S。

基本信息

  • 批准号:
    3289399
  • 负责人:
  • 金额:
    $ 17.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1986
  • 资助国家:
    美国
  • 起止时间:
    1986-01-01 至 1988-12-31
  • 项目状态:
    已结题

项目摘要

Biomaterial centered infections are increasingly caused by Staphylococcus epidermidis. Biomaterial surfaces that traverse the skin, such as sutures and catheters, are substrates for avid colonization by S. epidermidis. This organism has also become a principle pathogen in deep biomaterial infections. The adherence of S. epidermidis to surfaces and the persistence or virulence of this type of infection is related to a documented tendency to grow on substrates in biofilms within which its cells are protected from host defense factors by an exopolysaccharide matrix. Colonization of surfaces of transcutaneous and deep biomaterials is insidious because it does not immediately cause a clinical infection. In addition, clinicians have been reluctant to implicate this organism as a primary pathogen. S. epidermidis is autochthonous and is an initially non-invasive colonizer of surfaces of transcutaneous biomaterials; however, its sustained presence on biomaterials constitutes a reservoir from which it can emerge as an invasive pathogen. In Aim 1, we plan to examine the avidity of colonization of biomaterial substrates in an animal model using specific virulent and nonvirulent strains of S. epidermidis. In Aim 2, biochemical characterization of the exopolysaccharide of virulent encapsulated strains of S. epidermidis by gel chromatographic and compositional analysis will allow an understanding of the conversion of a virulent normal flora organism to a pathogen. In Aim 3, the adherence of S. epidermidis to biomaterials as they are prepared for surgical implantation, or as they have been modified (e.g., radio frequency glow discharge sterilized materials and antibiotic impregnated cement and synthetic vascular graft materials) will be quantified in an in vitro system. Antibiotic effectiveness against biofilm protected colonies on substrates will also be evaluated. Relevant surface factors of the biomaterials such as glycoproteinaceous conditioning films, surface energy and hydrophobicity will be considered. In Aim 4, purified exopolysaccharide of S. epidermidis will be tested for its influence on the function of macrophages including phagocytosis and bacterial killing. This comprehensive study will be conducted by three experienced investigators having combined expertise in surgical infections, biochemistry, microbiology, and immunology, and is of major importance because it will elucidate the critical factors responsible for the increasing and costly problem of biomaterial-associated infections.
以生物材料为中心的感染越来越多是由葡萄球菌引起的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANTHONY G. GRISTINA其他文献

ANTHONY G. GRISTINA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANTHONY G. GRISTINA', 18)}}的其他基金

IMMUNOGLOBULIN COATINGS TO PREVENT CATHETER INFECTION
免疫球蛋白涂层可预防导管感染
  • 批准号:
    2423523
  • 财政年份:
    1997
  • 资助金额:
    $ 17.74万
  • 项目类别:
PROVIDE SMALL INSTRUMENTATION
提供小型仪器
  • 批准号:
    2191064
  • 财政年份:
    1994
  • 资助金额:
    $ 17.74万
  • 项目类别:
BIOMATERIAL SUBSTRATES-S EPIDERMIDIS & PATHOGENICITY
生物材料基质-S表皮
  • 批准号:
    3289404
  • 财政年份:
    1990
  • 资助金额:
    $ 17.74万
  • 项目类别:
BIOMATERIAL SUBSTRATES-S EPIDERMIDIS & PATHOGENICITY
生物材料基质-S表皮
  • 批准号:
    3289403
  • 财政年份:
    1990
  • 资助金额:
    $ 17.74万
  • 项目类别:
BIOMATERIAL SUBSTRATES-S EPIDERMIDIS & PATHOGENICITY
生物材料基质-S表皮
  • 批准号:
    3289405
  • 财政年份:
    1990
  • 资助金额:
    $ 17.74万
  • 项目类别:
BIOMATERIAL SUBSTRATES OF S EPIDERMIDIS PATHOGENICITY
表皮致病性的生物材料基质
  • 批准号:
    2178140
  • 财政年份:
    1990
  • 资助金额:
    $ 17.74万
  • 项目类别:
BIOMATERIAL SUBSTRATES--S. EPIDERMIDIS & PATHOGENICITY
生物材料基材--S。
  • 批准号:
    3289402
  • 财政年份:
    1986
  • 资助金额:
    $ 17.74万
  • 项目类别:
BIOMATERIAL SUBSTRATES - S. EPIDERMIDIS & PATHOGENICITY
生物材料基材 - S. Epidermidis
  • 批准号:
    3289401
  • 财政年份:
    1986
  • 资助金额:
    $ 17.74万
  • 项目类别:
BACTERIAL COLONIZATION OF SURGICAL BIOMATERIALS
外科生物材料的细菌定植
  • 批准号:
    2078599
  • 财政年份:
    1981
  • 资助金额:
    $ 17.74万
  • 项目类别:
BACTERIAL COLONIZATION OF SURGICAL BIOMATERIALS
外科生物材料的细菌定植
  • 批准号:
    3155480
  • 财政年份:
    1981
  • 资助金额:
    $ 17.74万
  • 项目类别:

相似海外基金

Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
  • 批准号:
    2902098
  • 财政年份:
    2024
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
  • 批准号:
    BB/Y004035/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
  • 批准号:
    EP/Z533026/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
  • 批准号:
    FT230100468
  • 财政年份:
    2024
  • 资助金额:
    $ 17.74万
  • 项目类别:
    ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
  • 批准号:
    MR/Y033809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
  • 批准号:
    494853
  • 财政年份:
    2023
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
  • 批准号:
    2904356
  • 财政年份:
    2023
  • 资助金额:
    $ 17.74万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了